ZEKMED Information

ZEKMED’s origins are rooted in a collaborative network of innovators who strive in the development of applications/mediums/security using biometrics, Ai and blockchain technologies and the infinite influences these technologies will have on life. As a result of our developments in these fields with our project collaborators and likeminded partners, we found ourselves already engaged and working in the field of medical pre-diagnosis using biometric data for example the research into the pre-diagnosis of glaucoma. As a result of our developments in these fields with our project collaborators and likeminded partners, we found ourselves already engaged and working in the field of medical pre-diagnosis using biometric data for example the research into the pre-diagnosis of glaucoma. When the world was initially struck with the outbreak of the COVID-19 pandemic in December 2019, and by January 2020 it soon became clear that this was going to be an international public health emergency. As China went into lockdown, it was clear that others will follow and the virus was going to spread. The key to containing this flu like virus was going to be through testing. We quickly utilised our network of partners, and know-how in the field of pre-diagnosis to develop the components for our COVID-19 IGG/IGM Rapid test kit which is identified under our brand name of ZEKMED. Since ZEKMED initial creation, we have continued to improve the accuracy and quality of the ZEKMED rapid test with our partners.